SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2003

                            Commission File #2-89616

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)

                                     MONTANA
         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

                7500 San Felipe, Suite 600, Houston, Texas 77063
               (Address of principal executive offices)(Zip Code)

                                  713-914-8138
                (Registrant's telephone no., including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X] No [ ]

The number of shares outstanding of the Company's common stock as of March 31,
2003 is shown below:

Title of Class                                 Number of Shares Outstanding
Common Stock, par value $.001 per share        35,618,486

                   Documents Incorporated by Reference:  None


<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents

PART I - FINANCIAL INFORMATION

Item 1 - Financial Information

Item 2 -  Management's Discussion and Analysis of Financial Condition or Plan of
Operations

Item 3 -   Controls and Procedures


PART II - OTHER INFORMATION

Item 2 - Changes in Securities and Use of Proceeds

Item 6 - Exhibits and Reports on Form 8-K

SIGNATURES


<PAGE>
PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

The financial statements of the company are set forth beginning on page F-1.


<PAGE>
PART I - FINANCIAL INFORMATION
------------------------------

                          ITEM 1.  FINANCIAL STATEMENTS
AS  USED  HEREIN,  THE  TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC.  UNLESS  OTHERWISE  INDICATED.  CONSOLIDATED  UNAUDITED  INTERIM  FINANCIAL
STATEMENTS  INCLUDING  A  BALANCE  SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
MARCH  31,  2003,  STATEMENT  OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY  THIS  REFERENCE.






                 [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]






                                      F-2
<PAGE>
<TABLE>
<CAPTION>
                               CONSOLIDATED MINERALS MANAGEMENT, INC.
                                      (A MONTANA CORPORATION)
                                     CONSOLIDATED BALANCE SHEET
                                            (UNAUDITED)

                                               ASSETS
                                               ------


                                                               MARCH 31, 2003    DECEMBER 31, 2002
                                                              ----------------  -------------------
<S>                                                           <C>               <C>

Current Assets
--------------
  Cash                                                        $           988   $           63,076

                                                              ----------------  -------------------
      Total Current Assets                                                988               63,076

Oil & Gas Properties - Non Producing                                   84,958               65,322
                                                              ----------------  -------------------
      Total Assets                                            $        85,946   $          128,398
                                                              ================  ===================

                       LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                       ----------------------------------------------

Current Liabilities
-------------------
  Notes Payable-Current Portion                               $        25,767   $           25,767
  Accounts Payable                                                    108,012              108,012
  Accrued Officers' Salaries                                           44,250              100,000
  Accrued Expenses                                                    269,428              257,803
  Convertible Debentures                                              465,000              465,000
    and Notes Payable-Current Portion
                                                              ----------------  -------------------
      Total Current Liabilities                                       912,457              956,582

  Notes Payable - Long Term Portion                                    54,726               54,726

                                                              ----------------  -------------------
      Total Long-Term Liabilities                                      54,726               54,726

      Total Liabilities                                       $       967,183   $        1,011,308

Commitments and Contingencies:                                                                   -
------------------------------

Stockholders' Equity
--------------------
  Preferred Stock
    20,000,000 authorized shares, par value $.001             $             -   $                -
    no shares issued and outstanding

  Common Stock
  $0.001 par value, 50,000,000 shares authorized 35,618,486
  shares issued and outstanding as of March 31, 2003 and               35,618               28,683
  28,679,436 shares issued and outstanding as of December
  31, 2002.


  Additional Paid-in-Capital                                        3,817,049            3,675,535
  Stock Subscription Receivable                                        (4,000)             (67,250)
  Retained Earnings (Deficit)                                      (4,729,904)          (4,519,878)
                                                              ----------------  -------------------

      Total Stockholders' Equity (Deficit)                           (881,237)            (882,910)
                                                              ----------------  -------------------

      Total Liabilities and Stockholders' Equity (Deficit)    $        85,946   $          128,398
                                                              ================  ===================
</TABLE>


                                      F-3
<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
                             (A MONTANA CORPORATION)
                      CONSOLIDATED STATEMENT OF OPERATIONS
                                   (UNAUDITED)


                                    THREE MONTHS ENDED MARCH 31,
                                    ----------------------------
                                         2003           2002
                                    -------------  -------------
<S>                                 <C>            <C>
Revenues                            $          -   $          -
--------

Operating Expenses
  Personnel Costs                         19,000         43,563
  Consulting                               7,950        146,000
  Legal and Professional                   5,690         10,296
  Other Expenses                           3,471          8,902
                                    -------------  -------------

  Total Operating Expenses          $     36,111   $    208,761

Income (Loss) from Operations            (36,111)      (208,761)

Other Income (Expenses)
  Interest Expense                       (11,625)       (11,625)

                                         (11,625)       (11,625)

Income (Loss) before Income Taxes   $    (47,736)  $   (220,386)

Income Tax Expense                             -              -
                                    -------------  -------------

Net Income (Loss)                   $    (47,736)  $   (220,386)
                                    =============  =============
Net Income (Loss) per Share         $    (0.0032)  $     0.0444
                                    =============  =============
                                               -
</TABLE>


                                      F-4
<PAGE>
<TABLE>
<CAPTION>
                                   CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                          (A MONTANA CORPORATION)
                                    CONSOLIDATED STATEMENT OF CASH FLOWS
                                                (UNAUDITED)


                                                                           THREE MONTHS ENDED MARCH 31,
                                                                             2003               2002
                                                                       -----------------  -----------------
<S>                                                                    <C>                <C>

Cash Flows from Operating Activities:
------------------------------------
  Net Income (Loss)                                                    $        (47,736)  $       (220,386)
  Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by
    Operating Activities:
      Depreciation and Amortization                                                   -                  -
      Non Cash Consulting and Services Paid by Stock Issue                            -            146,000
      (Increase) Decrease in Receivables                                              -            (23,952)
      (Decrease) Increase in Accounts Payable                                         -              5,012
      (Increase) Decrease in Interest Payable                                    11,625             11,625
      (Increase) Decrease in Accrued Expenses                                         -                  -
                                                                       -----------------  -----------------
           Net Cash Provided (Used) by Operating Activities            $        (36,111)  $        (81,701)
                                                                       -----------------  -----------------

Cash Flows from Investing Activities:
------------------------------------
                                                                                      0
  Note Receivable - Collections                                                       -             55,453
  Oil & Gas Properties - Non Producing                                          (19,636)                 -
                                                                       -----------------  -----------------

           Net Cash Provided (Used) by Investing Activities            $        (19,636)  $         55,453
                                                                       -----------------  -----------------

Cash Flows from Financing Activities:
------------------------------------

  Proceed from Notes Payable                                                          -              7,600
  Common Stock                                                                        -             17,011
                                                                       -----------------  -----------------

           Net Cash Provided (Used) by Financing Activities            $              -   $         24,611
                                                                       -----------------  -----------------

Net Increase (Decrease) in Cash                                        $        (55,747)  $         (1,637)

Cash, Beginning of period                                                        63,076              5,470
                                                                       -----------------  -----------------

Cash, End of period                                                    $            988   $          3,833

Supplemental Disclosure of Cash Flow Information                       $         62,088
  Cash Paid During the Period for:                                     $          6,341
    Interest                                                           $              -   $              -
                                                                       =================  =================
    Income Taxes                                                       $              -   $              -
                                                                       =================  =================

Supplemental Disclosure of Non-Cash Financing Information:
  In the quarter ended March 31, 2003 and 2002,
    Non Cash Consulting and Services Paid by Stock Issue               $              -   $        146,000
</TABLE>


                                      F-5
<PAGE>
                    Consolidated Medical Management Inc. Inc.
                          Notes to Financial Statements

NOTE 1 - BASIS OF PRESENTATION
------------------------------

GENERAL
-------
The  consolidated  unaudited  interim  financial statements of the Company as of
March  31,  2003  and for the three months ended March 31, 2003, included herein
have  been prepared in accordance with the instructions for Form 10QSB under the
Securities  Exchange  Act  of 1934, as amended, and Article 10 of Regulation S-X
under the Securities Act of 1933, as amended. The December 31, 2002 Consolidated
Balance  Sheet  was  derived  from  audited  financial  statements, but does not
include  all  disclosures  required by generally accepted accounting principles.
Certain  information  and  note  disclosures  normally  included  in  financial
statements  prepared in accordance with generally accepted accounting principles
have  been  condensed or omitted pursuant to such rules and regulations relating
to  interim  consolidated  financial  statements.

In  the  opinion  of management, the accompanying consolidated unaudited interim
financial  statements  reflect  all  adjustments,  consisting  only  of  normal
recurring adjustments, necessary to present fairly the financial position of the
Company  at  March  31,  2003, and the results of their operations for the three
months  ended March 31, 2003 and 2002, and their cash flows for the three months
ended  March  31,  2003  and  2002.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2002 and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission

                                  ORGANIZATION
The Company was incorporated under the laws of the State of Montana on August
13, 1981.  The Company ceased its mining operations in 1985, and discontinued
all business operations in 1990.  In August of 2001, the Company decided to
refocus on the oil and gas industry and entered into several Letters of Intent
only one of which survived the due diligence process.


                                      F-6
<PAGE>
                      Consolidated Medical Management, Inc.
                          Notes to Financial Statements


NOTE 2  -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
-----------------------------------------------------

ACCOUNTING METHOD
-----------------
Accounting  policies of the Company conform to the generally accepted accounting
principles  and  reflect  practices  appropriate  to  the  industry  in which it
operates.  The  significant  policies  are  summarized  below.

CASH  FLOWS  AND  CONCENTRATION  OF  CREDIT  RISK

Cash  consists  principally  of  demand  deposits  at  commercial  banks.  These
balances, as reflected in the bank's records, are insured by the Federal Deposit
Insurance  Corporation up to $100,000.  At December 31, 2002 and March 31, 2003,
the  Company's  deposits  did  not  exceed  the  insured  limits.

EARNINGS PER COMMON SHARE
-------------------------
The  Company adopted Financial Accounting Standards  (SFAS) No.  128,  "Earnings
Per Share," which simplifies the computation of earnings per share requiring the
restatement  of  all  prior  periods.

Basic  earnings  per  share  are  computed  on the basis of the weighted average
number  of  common  shares  outstanding  during  each  year.

Diluted  earnings  per  share  are computed on the basis of the weighted average
number  of  common  shares  and  dilutive  securities  outstanding.  Dilutive
securities  having  an  anti-dilutive  effect  on diluted earnings per share are
excluded  from  the  calculation.  The  Company  does  not  have  any  dilutive
securities  as  of  March  31,  2002.

RITICAL  ACCOUNTING  POLICIES  AND  ESTIMATES

The  preparation  of  financial statements requires management to make estimates
and assumptions that affect reported earnings. The estimates and assumptions are
evaluated  on  an  on-going  basis and are based on historical experience and on
other factors that management believes are reasonable. Estimates and assumptions
include, but are not limited to commitments and contingencies.

The Company believes that the following represent the areas where more critical
estimates  and  assumptions  are  used  in  the  preparation  of  the  financial
statements:

LONG-LIVED  ASSET IMPAIRMENTS: The Company records impairments when the carrying
amounts of long-lived assets are determined not to be recoverable. Impairment is
assessed  and  measured  by  an estimate of future cash flows expected to result
from  the  use  of  the  asset  and  its eventual disposition. Changes in market
conditions  can  impact estimated future cash flows from use of these assets and
impairments  charges  may  be  required  should  such  changes  occur.

NOTE 3  -  CONVERTIBLE DEBENTURES AND NOTES PAYABLE
---------------------------------------------------

The Company issued convertible debentures in 1998 that are subordinated to bank
debt and secured leases.  The debentures are otherwise unsecured but are given a
preference over unsecured debt. The debentures include interest at fifteen (15%)
percent, interest is payable in monthly installments.  Each debenture has a
conversion right for each holder to convert the debenture principal to shares of
the Company's common stock at the greater of $2.50 per share or ninety (90%)
percent of the bid price, whichever is greater on the date of conversion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion.  The debentures are due one year from date of
issue. All debentures issued in 1998 were due in 1999, and they are in default
as of March 31, 2003.

The Company issued convertible promissory notes payable in 1998.  The notes are
unsecured and include interest at ten (10%) percent, interest is payable in
monthly installments.  Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion. As of December 31, the company had issued and
outstanding $325,000 in debentures.  The notes were due July 31, 1999, and they
are in default as of March 31 2003.


                                      F-7
<PAGE>
                      Consolidated Medical Management, Inc.
                          Notes to Financial Statements


NOTE 3  -  CONVERTIBLE DEBENTURES AND NOTES PAYABLE (CON'T)
-----------------------------------------------------------

The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions.  In exchange,
Spectrum will then receive an unsecured note payable from the Company (see Note
7) for the face amount of the debenture surrendered.  During the year ended
December 31, 1998, Spectrum exchanged a total of 14,000 of its shares in
connection with this agreement and received five notes payable from the Company
totaling $35,000.



     Total Convertible Debentures and Notes Payable     $       465,000
     Less: Current Portion                                     (465,000
                                                       ----------------
     Long-Term Portion                                 $             -0
                                                       ================

NOTE  4  -  COMMON  AND  PREFERRED  STOCK
-----------------------------------------

COMMON STOCK
------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of as of December 31, 2002 and March 31, 2003, the Company had
28,679,436 and 35,618,486 shares issued and outstanding, respectively.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock.  There
are 20,000,000 shares authorized with a par value of $ 0.001.  The shares are
non-voting and non-redeemable by the Company.  The Company further designated
two series of its Preferred Stock:  "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares.  As of
March 31, 2003 and December 31, 2002 there are no shares issued and outstanding.

DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on the day prior to each such  respective dividend payment date.  In no event
shall the holders of either series receive dividends of more than percent (1%)
in any fiscal year.  Each share of both series shall rank on parity with each
other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.


                                      F-8
<PAGE>
                      Consolidated Medical Management, Inc.
                          Notes to Financial Statements


CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time. Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" of $ 12.50 Preferred Stock.  The Series "A" $12.50 Preferred
Stock shall be convertible, in whole or in part, at any time after the common
stock of the Company shall maintain an average bid price per share of at least
$12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock.  The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of  either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share,  plus
the amount of any dividends declared and unpaid thereon.

NOTE 5 - COMMITMENT AND CONTINGENCIES

The Company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern. The stockholders/officers and or directors have committed to
advancing operating costs of the Company interest free


                                      F-9
<PAGE>
ITEM 2.  MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF
OPERATIONS.

The  following  discussion  should  be  read  in  conjunction with our unaudited
consolidated  interim financial statements and related notes thereto included in
this  quarterly  report and in our audited consolidated financial statements and
Management's  Discussion  and  Analysis  of  Financial  Condition and Results of
Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31,
2002.  Certain  statements in the following MD&A are forward looking statements.
Words  such as "expects", "anticipates", "estimates" and similar expressions are
intended  to identify forward looking statements. Such statements are subject to
risks  and  uncertainties  that  could cause actual results to differ materially
from  those  projected.

GENERAL

Consolidated Medical Management, Inc. ("CMMI"), was incorporated under the laws
of the State of Montana on August 13, 1981 under the name Golden Maple Mining
and Leaching Company, Inc.  On May 23, 1998, we changed our name to Consolidated
Medical Management, Inc. In August 2001, the Company decided to refocus on the
oil and gas industry and are currently doing business as Consolidated Minerals
Management, Inc. CMMI's address was 5161 San Felipe, Suite 320, Houston, Texas
77056 until June 2003 when the company moved offices to 7500 San Felipe, Suite
600, Houston, Texas 77063.

RESULTS OF OPERATIONS

CMMI secured funding that enabled the Company to drill two Nacatoch wells in
Caddo Parrish, Louisiana. In December 2002, CMMI sold their interest in the
Nacatoch Light #1 and Bell #7 wells for $75,000. CMMI has successfully raised
the capital to develop 10 additional Nacotoch wells in Caddo Parish, LA.  A
third well has been drilled and the Company is awaiting the results.

The Company acquired a 5% working interest in PAR Minerals Corporation's Snake
Bite Prospect (Richardson #1) in Edwards County, Texas. CMMI has partnered with
PAR in an Ellenberger horizontal test. The well began generating revenue sales
on March 16, 2003. Current plans are to try and acquire additional drill sites
in the immediate area.

COMPARISON OF QUARTER ENDED MARCH 31, 2003 TO THE QUARTER ENDED MARCH 31, 2002

For the quarter ended March 31, 2003, our net loss was $43,736 as compared to
$220,386 for the quarter ended March 31, 2002.  The decrease is related to a
decrease in consulting fees incurred from assistance developing a focused
business plan and strategy for obtaining the debt or equity financing that we
will need to acquire energy prospects.

Total Operating Expenses decreases from $208,761 in the first quarter 2002 to
$36,111 in 2003.  This was primarily due to a decrease in consulting expenses or
stock based compensation.   Stock-based compensation declined based on decreased
activity in the Company as plans were made to develop two leases in Texas and
Louisiana.


LIQUIDITY AND CAPITAL RESOURCES

The Company used funds from private placements received from investors to invest
in  two  oil  and gas as well as to operate the company.  The Company will begin
generating  some  revenue  from these investments in the second quarter of 2003.

Currently,  the  liabilities  shown  on  the  balance  sheet  are  current trade
payables,  and  accrued  expenses  and convertible debenture expenses related to
financing  activities  when  the Company was engaged in the delivery of turn-key
management  services  for  the  home  health  industry,  predominately  in south
Louisiana

Continuing  negative  operating  results  produced  a working capital deficit of
$793,506 for the year ended December 31, 2002.  The Company's recurring negative
financial  results  raise  substantial  doubt  about  the  Company's  ability to
continue  as  a  going  concern.


<PAGE>
The Company currently anticipates that its existing cash and cash equivalents
balance will fund operations and continue energy development at the current
level of activity into the third quarter of 2003. The Company will need to raise
additional funds through additional debt or equity financing. There can be no
assurance that additional equity or debt financing will be available when needed
or on terms acceptable to the Company.

The market price of the Company's common stock has fluctuated significantly
since it began to be publicly traded in 1998 and may continue to be highly
volatile. Factors such as the ability of the Company to achieve development
goals, ability of the Company to profitably complete energy projects, the
ability of the Company to raise additional funds, general market conditions and
other factors affecting the Company's business that are beyond the Company's
control may cause significant fluctuations in the market price of the Company's
common stock. The market prices of the stock of many energy companies have
fluctuated substantially, often unrelated to the operating or research and
development performance of the specific companies. Such market fluctuations
could adversely affect the market price for the Company's common stock.

CRITICAL  ACCOUNTING  POLICIES  AND  ESTIMATES

The  Company's discussion and analysis of its financial condition and results of
operations are based upon its consolidated financial statements, which have been
prepared  in  accordance  with  generally  accepted accounting principles in the
United  States.  The  preparation  of  these  financial  statements requires the
Company  to  make  estimates  and  judgments that affect the reported amounts of
assets,  liabilities, revenue and expenses, and related disclosure of contingent
assets  and  liabilities.  On  an  ongoing  basis,  the  Company  evaluates  its
estimates.  The  Company  bases  its  estimates  on historical experience and on
various  other  assumptions  that  are  believed  to  be  reasonable  under  the
circumstances.  These  estimates  and  assumptions  provide  a  basis for making
judgments  about  the  carrying  values  of  assets and liabilities that are not
readily  apparent  from  other  sources.  Actual  results  may differ from these
estimates  under  different assumptions or conditions, and these differences may
be  material.

The Company believes the following critical accounting policies affect its more
significant judgments and estimates used in the preparation of its consolidated
financial statements.

FORWARD-LOOKING INFORMATION - GENERAL
This report contains a number of forward-looking statements, which reflect the
Company's current views with respect to future events and financial performance
including statements regarding the Company's projections. These forward-looking
statements are subject to certain risks and uncertainties that could cause
actual results to differ materially from historical results or those
anticipated. In this report, the words "anticipates", "believes", "expects",
"intends", "future", "plans", "targets" and similar expressions identify
forward-looking statements. Readers are cautioned to not place undue reliance on
the forward-looking statements contained herein, which speak only as of the date
hereof the Company undertakes no obligation to publicly revise these
forward-looking statements, to reflect events or circumstances that may arise
after the date hereof. Additionally, these statements are based on certain
assumptions that may prove to be erroneous and are subject to certain risks
including, but not limited to, the Company's dependence on limited cash
resources, and its dependence on certain key personnel within the Company.
Accordingly, actual results may differ, possibly materially, from the
predictions contained herein.

ITEM 3.  CONTROLS AND PROCEDURES.
Timothy G. Byrd, Sr., our Chief Executive Officer and Acting Chief Accounting
Officer, has concluded that our disclosure controls and procedures are
appropriate and effective.   He has evaluated these controls and procedures as
of a date within 90 days of the filing date of this report on Form 10-QSB.
There were no significant changes in our internal controls or in other factors
that could significantly affect these controls subsequent to the date of their
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.


<PAGE>
                                     PART II

Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.

ITEM 2.  CHANGES IN SECURITIES

The following information sets forth certain information for all securities the
Company issued from January 1, 2003 through March 31, 2003, in transactions
without registration under the Act.  There were no underwriters in any of these
transactions, nor were any sales commissions paid thereon. The securities were
issued pursuant to Section 4(2) of the Act.

2,460,550 shares were issued for services. 1,325,000 shares were issued as
compensation to officers and directors, while 3,000,000 were issued pursuant to
employment agreements.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

None



                                   SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange
Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on
its behalf by the undersigned, there unto duly authorized, in the City of
Houston, Texas, on May 20, 2003.

CONSOLIDATED MEDICAL MANAGEMENT, INC.

By: /s/ Timothy G. Byrd, Sr.
    ------------------------
---------------------------------------------
       Timothy G. Byrd, Sr.
       Chief Executive Officer, Acting Chief Accounting Officer, and Director


<PAGE>
Certifications

I, Timothy G. Byrd, Sr., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Consolidated Medical
Management, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and
c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):
a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and
6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: May 20, 2003
/s/ Timothy G. Byrd, Sr.
------------------------
Timothy G. Byrd, Sr.
Chief Executive Officer


<PAGE>
I, Timothy G. Byrd, Sr., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Consolidated Medical
Management, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and
c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):
a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and
6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: May 20, 2003
/s/Timothy G. Byrd, Sr.
-----------------------
Timothy G. Byrd, Sr.
Acting Chief Accounting Officer


<PAGE>
Certification of Chief Executive Officer and Acting Chief Accounting Officer of
-------------------------------------------------------------------------------
Consolidated Medical Management, Inc. pursuant to Section 906 of the
--------------------------------------------------------------------
Sarbanes-Oxley Act of 1992 and Section 1350 of 18 U.S.C. 63.
-----------------------------------------------------------

I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting
Officer of Consolidated Medical Management, Inc. hereby certify that to my
knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for
the period ended March 31, 2003, fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in the periodic report on Form 10-QSB and the financial statements
contained therein fairly presents, in all material respects, the financial
condition and results of the operations of Consolidated Medical Management, Inc.

Date:  May 20, 2003                   /s/ Timothy G. Byrd, Sr.
                                      ------------------------
                                      Timothy G. Byrd, Sr.,
                                      Chief Executive Officer
                                      Consolidated Medical Management, Inc.



Certification of Chief Executive Officer and Acting Chief Accounting Officer of
-------------------------------------------------------------------------------
Consolidated Medical Management, Inc. pursuant to Section 906 of the
--------------------------------------------------------------------
Sarbanes-Oxley Act of 1992 and Section 1350 of 18 U.S.C. 63.
-----------------------------------------------------------

I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting
Officer of Consolidated Medical Management, Inc. hereby certify that to my
knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for
the period ended March 31, 2003, fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and that information
contained in the periodic report on Form 10-QSB and the financial statements
contained therein fairly presents, in all material respects, the financial
condition and results of the operations of Consolidated Medical Management, Inc.

Date: May 20 2003             /s/Timothy G. Byrd, Sr.
                              -----------------------
                              Timothy G. Byrd, Sr.,
                              Acting Chief Accounting Officer of
                              Consolidated Medical Management, Inc.


<PAGE>